Patent application number | Description | Published |
20090011018 | Sustained release formulation for tacrolimus - A sustained release pharmaceutical composition for tacrolimus, comprising a solid dispersion containing tacrolimus or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a dissolution rate of tacrolimus after 4 hours from the beginning of a dissolution test is less than 35%, is disclosed. | 01-08-2009 |
20110142933 | Controlled Release Dosage Form of Tacrolimus - A controlled release dosage form of tacrolimus, comprising a solid dispersion of tacrolimus, wherein a controlled release base, which is selected from the group consisting of a water-soluble macromolecule, a gum base, and a membrane forming agent and does not form the solid dispersion of tacrolimus, is further contained, is disclosed. The controlled release dosage form of tacrolimus has an excellent controlled release and shows a stable blood concentration. | 06-16-2011 |
20110281906 | SUSTAINED RELEASE FORMULATION FOR TACROLIMUS - A sustained release pharmaceutical composition for tacrolimus, comprising a solid dispersion containing tacrolimus or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a dissolution rate of tacrolimus after 4 hours from the beginning of a dissolution test is less than 35%, is disclosed. | 11-17-2011 |
20140178756 | COMPOSITE PARTICLES FOR ELECTROCHEMICAL DEVICE ELECTRODE, MATERIAL FOR ELECTROCHEMICAL DEVICE ELECTRODE, ELECTROCHEMICAL DEVICE ELECTRODE, AND ELECTROCHEMICAL DEVICE - Composite particles for electrochemical device electrode containing an electrode active material and a particle-shaped binder, wherein said binder includes a copolymer which contains a nitrile group-containing monomer unit, a monomer unit which has an acidic functional group, and a monomer unit which contains a C | 06-26-2014 |
20140342225 | ELECTRODE FOR ELECTROCHEMICAL DEVICE - An electrode for electrochemical device which is provided with an electrode active material layer containing an electrode active material and a binder, comprising binder-covered parts | 11-20-2014 |
20150038837 | DEVICE FOR DETERMINING METASTASIS OF CANCER TO SENTINEL LYMPH NODE - Provided is a device capable of determining whether or not cancer has metastasized to a sentinel lymph node, such as the axillary lymph node, thickly covered with fat, safely and in a simple manner without confirmation by biopsy or extirpation. Fluorescence generated in a sentinel lymph node upon the excitation of protoporphyrin (a photosensitizing substance) derived from 5-ALA administered to a subject can be detected by passing a hollow tube, into which a small-diameter optical fiber for launching light and the small-diameter optical fiber for receiving light are inserted, through the lymph vessel to identify the presence or absence of the metastasis of cancer cells even before the surgery of cancer or during prognosis. | 02-05-2015 |
20150125755 | COMPOSITE PARTICLES FOR ELECTROCHEMICAL DEVICE ELECTRODE, ELECTROCHEMICAL DEVICE ELECTRODE, AND ELECTROCHEMICAL DEVICE - Composite particles for electrochemical device electrode comprising a first particle-shaped binder with a glass transition temperature of 5° C. or less, a second particle-shaped binder with a glass transition temperature of 10 to 80° C. and with a gel content of 70 wt % or more, and an electrode active material, wherein a ratio of content of said second particle-shaped binder is 30 to 95 wt % in the total binder which is contained in said composite particles for electrochemical device electrode, are provided. | 05-07-2015 |
20150297720 | PHOTODYNAMIC DIAGNOSTIC AGENT AND PHOTOBLEACHING INHIBITOR - The objects of the present invention are to inhibit photobleaching of porphyrins as well as to provide a superior photodynamic diagnostic agent and a photodynamic diagnostic method employing the photobleaching inhibitor for porphyrins. The present invention provides a photodynamic diagnostic agent containing a precursor of porphyrins and a gallic acid. The present invention also provides a photobleaching inhibitor for porphyrins containing a gallic acid. | 10-22-2015 |